This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 3 weeks ago
2 images for "Byetta"
Amylin/Eli Lilly (2009) Byetta summary of product characteristics. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf [Accessed 8 May 2014]. Baggio, L. and Drucker, D. (2007) Biology of incretins: ...General Medicine eJournal, 1 month ago
A tip of the hat to our friend and former colleague Ken Zucker from Pepper Hamilton , who achieved this victory and sent us the decision. In the consolidated California Byetta litigation, 2015WL 663211 (Cal. Super. Feb. 26, 2015), defendant Eli ...JD Supra, 2 weeks ago
Ellie Lobel was ready to die. Then she was attacked by bees. Christie Wilcox hears how venom can be a saviour. "I moved to California to die." Ellie Lobel was 27 when she was bitten by a tick and contracted Lyme disease. And she was not yet ...Gizmodo, 1 week ago
Sanofi has released top-line results of its Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) study, the cardiovascular-outcomes trial for its glucagonlike peptide (GLP-1) agonist for the treatment of type 2 diabetes, lixisenatide ( ...Dermatology Online Journal, 1 week ago
Q. My wife is taking Januvia to control her blood sugar. Without Januvia her sugar level is 130 or more. With Januvia it is in the range of 110, which is close to normal. I heard an interview on the radio that three medications to reduce blood ...Peoples Pharmacy, 1 week ago
Operator Please standby, we are about to begin. Good morning, ladies and gentlemen. And welcome to the Flamel Technologies Fourth Quarter 2014 Results Conference Call. Please note that this call is being recorded. Now, Id like to turn the call ...Seeking Alpha, 1 week ago Antares Pharma (ATRS) CEO Eamonn Hobbs on Q4 2014 Results - Earnings Call Transcript Seeking Alpha, 2 weeks ago AstraZeneca Group's (AZN) CEO Pascal Soriot on Q4 2014 Results - Earnings Call Transcript Seeking Alpha, 1 month ago
Sanofi ($SNY) can go back to the FDA with Lyxumia. The French drugmaker got good news from a cardiovascular outcomes study, required by the FDA before it would approve the diabetes drug. Lyxumia (lixisenatide) proved no more risky to the heart ...FiercePharma, 1 week ago
A 72-year-old man presented in follow-up for insulin-requiring new-onset diabetes after kidney transplant. The patient had a history of hepatitis C virus infection, which led to hepatorenal syndrome. Subsequent end-stage renal disease necessitated a ...Orthopedics Today, 1 week ago
9-Mar-2015 Biotechnology | North America Adocia, a French biotechnology company that specialises in the development of innovative formulations of already approved therapeutic proteins, has opened a subsidiary in the US called Adocia ...Manufacturing Chemist, 3 weeks ago ADOCIA : Opens a Subsidiary in the USA and is Pleased to Appoint Simon Bruce, MD and Stephen Daly 4 Traders, 3 weeks ago
More from: , Nasdaq...and 4 other sources
on your WebpageAdd Widget >Get your members hooked!